BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 27, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 8, 2002
View Archived Issues
Immunex Starts Second Phase III Study Of Enbrel For Psoriasis
Immunex Corp. said at the 20th annual World Congress of Dermatology Meeting in Paris that it began a second Phase III trial of Enbrel in psoriasis as the company seeks its fifth approval for the drug. (BioWorld Today)
Read More
TransMolecular Fighting Cancer With The Help Of Scorpion Toxin
Read More
To Quell HIV's Inexorable Strain Variability, Alamos Lab Proposes Country-Defined AIDS Vaccines
Read More
Gerberding Named Director Of Centers For Disease Control
Read More
Holiday Notice
Read More
VaxGen, Genentech Revise Agreement On AIDS Vaccine
Read More
Other News To Note
Read More
Appointments And Advancements
Read More